Peptides for Hair Growth: 2026 Market Data Reveals 12% CAGR in Clinical Trials and Product Efficacy
Abstract: The 2026 market data reveals a 12% CAGR for peptides in hair growth, driven by clinical trials confirming efficacy. Product compositions now feature copper, collagen, and growth factor peptides, outperforming traditional minoxidil in safety and follicle stimulation. Industry insights highlight formulation synergy with biotin and stem cell extracts. Selection guides prioritize purity, molecular weight, and clinical backing. This segment is poised for expansion as consumer demand shifts toward science-backed, non-invasive solutions.